Health & Well-Being
UConn Health, Connecticut Children’s, to Host First Gene Therapy Trial for GSD
The trial will test a gene therapy developed by Dr. David Weinstein that is designed to improve glucose control by replacing the deficient enzyme in a patient’s liver.
Achieving a Healthier You After Breast Cancer
To prevent cancer, 'We must return to basics and follow a daily prescription of a healthy diet and exercise,' says UConn Health's Dr. Susan Tannenbaum.
Men May Experience Weight Stigma as Much as Women
A new study by the UConn Rudd Center finds that a significant portion of adult American men report being mistreated about their weight.
First Potential Biomarker for Noise-Induced Hearing Loss Identified
UConn Health physician-researcher Kourosh Parham says the new biomarker may facilitate early diagnosis of hearing loss in patients before their condition becomes severe.
Spider Silk Key to New Bone-Fixing Composite
A UConn materials science team has developed an innovative composite for healing broken load-bearing bones based on a protein found in the silk fibers spun by spiders.
Light at Night Can Disrupt Circadian Rhythms in Children. Are There Long-Term Risks?
There are at least three reasons that too much light during the evening could matter to the health of children, and all are terrible: depression, suicide, and cancer, writes Richard Stevens of UConn Health.
New Compound Helps Activate Cancer-Fighting T Cells
UConn researchers have identified mechanisms responsible for improved immune system activity, offering new approaches for more effective cancer treatments and vaccines.
Bones in All the Wrong Places
UConn researchers have shown how a mutation causes certain cells in muscle tissue to develop into cartilage and bone at injury sites.
Who is Keeping Track of All Those Pills?
UConn pharmacy faculty are working at the state level to address the problem of patients taking multiple medications for different conditions with little coordination.
New Study Identifies Effective Treatments for Persistent Asthma
UConn-led study in the Journal of the American Medical Association finds using a single steroid-bronchodilator treatment for both persistent asthma control and rescue relief resulted in fewer asthma attacks.